The Super Network of Premier Research Sites
Our site is currently under revision.
Check back soon for updated content.

Who is hyperCORE International?

hyperCORE International is a super network of highly experienced and awarded clinical trial sites working together to accelerate and advance clinical research. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. Currently, hyperCORE International is comprised of 8 alliance partners with over 100 sites spanning 2 continents and 5 countries.

hyperCORE International Partners

hyperCORE International brings together the clinical research industry’s most respected and advanced clinical trial companies, facilitating a level of collaboration unmatched in scope – its sole purpose is to advance the efficiency of clinical trials and ultimately improve the health and wellbeing of diverse populations across the globe. The collaboration between hyperCORE’s alliance partner companies is reflective of an industry demand for more professionalized and efficient models for the delivery of clinical trials. Each alliance partner is thoroughly vetted prior to acceptance, reflecting hyperCORE’s values in superior quality, experience, efficiency and industry leadership.

When you need the Premier Global Network

hyperCORE International is strategically prepared to assist you through COVID-19 and beyond.

hyperCORE International Executives

Integrated by high-quality professionals, with more than 30 years of experience in clinical research, driven by the mission to improve and innovate healthcare. Learn more about the incredible executive team helping us accelerate clinical research.

“hyperCORE International is one of the premier integrated research networks in the industry and I am honored to be voted in as CEO from my peers to take on the leadership of this amazing team. In a time of uncertainty, research has a vital role in finding a solution to this pandemic and the future of research sites is changing rapidly of which hyperCORE International is poised to be leading”

- Karri Venn, CEO
Play Video
Total Available Patient for Recruitment


Total Sites: 2 Continents, 5 Countries


Total Principal Investigators


Total Therapeutic Areas


Total Trials Conducted


Total Patients Randomized